![](/img/cover-not-exists.png)
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
Yi Zhang, Anieta M. Sieuwerts, Michelle McGreevy, Graham Casey, Tanja Cufer, Angelo Paradiso, Nadia Harbeck, Paul N. Span, David G. Hicks, Joseph Crowe, Raymond R. Tubbs, G. Thomas Budd, Joanne Lyons,Volume:
116
Language:
english
Pages:
7
DOI:
10.1007/s10549-008-0183-2
Date:
July, 2009
File:
PDF, 321 KB
english, 2009